Sheffield Wednesday’s prospective new owners will be able to buy the club without going through the Independent Regulator's new beefed-up owners and directors test – but could be subjected to it later ...

The Office of the Comptroller of the Currency (OCC) has issued new guidance confirming that U.S. national banks may hold small amounts of crypto-assets on their balance sheets for the explicit purpose ...

Seth Grae, President, CEO & Chairman of the Board, highlighted that "the first 9 months of this year have been marked by unprecedented operational milestones and an increasingly favorable political ...

X-energy Reactor Company, LLC, ("X-energy" or the "Company") today announced the start of confirmatory irradiation testing at Idaho National Laboratory (“INL”) to qualify the Company’s proprietary ...

Chainlink and Apex Group said they completed a pilot project with Bermuda’s financial regulator, the Bermuda Monetary Authority, to test how blockchain infrastructure can help enforce stablecoin rules ...

We got a sneak peek inside Found Energy’s lab, just as it gears up to supply heat and hydrogen to its first customer. The crushed-up soda can disappears in a cloud of steam and—though it’s not visible ...

Your car's engine needs a very specific diet of air and fuel to do its job, and it's the fuel pressure regulator's (FPR) job to feed it the right amount. The gadget is relatively tiny and can fit in ...

Tesla CEO Elon Musk helped fire dozens of workers at the National Highway Traffic Safety Administration earlier this year. This week, the U.S. Senate voted 51-47 to confirm Jonathan Morrison to lead ...

The EU’s landmark crypto law was meant to unify the market with a single license. Less than a year in, diverging national approaches are raising fears of regulatory arbitrage and uncertainty. As the ...

The Independent Football Regulator (IFR) has revealed the first weapon in its arsenal to protect English clubs from bankruptcy: a beefed-up fit-and-proper person test that could see rogue owners ...

Trinity Biotech's American depositary receipts surged after the company received approval from New York regulators to start providing tests that assess the risk of preeclampsia in pregnant patients.